Immune and targeted therapy for cancer: time to rethink restrictions for the treatment of the elderly and frail

Immune and targeted therapy for cancer: time to rethink restrictions for the treatment of the elderly and frail

Targeted and immunotherapy have revolutionized cancer treatment. They safely substitute for traditional chemotherapy in a significant and growing number of malignancies. In this article, we review the United States Food and Drug Administration (FDA) - approved targeted and immunotherapies, currently...

Full description

Bibliographic Details
Main Authors: Juliana Rodrigues Beal, Gustavo Schvartsman, Rodrigo Ramella Munhoz, Theodora Karnakis, Rafael Aliosha Kaliks
Format: Article
Language:English
Published: Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2021-10-01
Series:Brazilian Journal of Oncology
Subjects:
molecular targeted therapy
immunotherapy
therapeutics
frail elderly
aged
Online Access:http://www.brazilianjournalofoncology.com.br/details/162/en-US/immune-and-targeted-therapy-for-cancer--time-to-rethink-restrictions-for-the-treatment-of-the-elderly-and-frail

Internet

http://www.brazilianjournalofoncology.com.br/details/162/en-US/immune-and-targeted-therapy-for-cancer--time-to-rethink-restrictions-for-the-treatment-of-the-elderly-and-frail

Similar Items